Ads
related to: list of platelet inhibitors for prostate cancer symptoms and treatment- Educational Brochures
Get Resources Now For
APC Treatment
- Safety & Efficacy Video
Watch A Video To Learn
More About This Treatment Option.
- Coverage for Rx Treatment
Learn About Coverage
In Your Area
- Patient Support Program
Support to Help Your Patients
Get Started and Stay on Track
- Access Patient Resources
Download Dosing Card &
Support Program Brochure
- Prescribing Information
Advanced Prostate Cancer Treatment
View Prescribing Information
- Educational Brochures
Search results
Results From The WOW.Com Content Network
Prostate cancer: Myelosuppression, diarrhoea, kidney failure, hypersensitivity, severe GI reactions (including perforation, ileus, colitis, etc.; all rare) and peripheral neuropathy Docetaxel: IV: As above. Breast cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, squamous cell head and neck cancer and gastric cancer.
An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation [1] and inhibit thrombus formation.
Surgical removal of the prostate, or prostatectomy, is a common treatment either for early-stage prostate cancer or for cancer that has failed to respond to radiation therapy. The most common type is radical retropubic prostatectomy , when the surgeon removes the prostate through an abdominal incision.
Flutamide (Eulexin): Marketed for the treatment of prostate cancer and also used in the treatment of acne, hirsutism, and hyperandrogenism in women. [3] [4] It has also been studied in the treatment of benign prostatic hyperplasia. [6] Now little-used due to high incidence of elevated liver enzymes and hepatotoxicity and the availability of ...
In the EPC trial, in which bicalutamide monotherapy (150 mg/day) was evaluated for treatment of early prostate cancer in 8,113 men, the incidence of abnormal liver function tests at 3-year median follow-up was 3.4% for bicalutamide plus standard care (n=4,052) and 1.9% for standard care alone (n=4,061).
Prostacyclin, which has a half-life of 42 seconds, [9] is broken down into 6-keto-PGF 1, which is a much weaker vasodilator.A way to stabilize prostacyclin in its active form, especially during drug delivery, is to prepare prostacyclin in alkaline buffer.
Ad
related to: list of platelet inhibitors for prostate cancer symptoms and treatment